Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium flag Belgium · Delayed Price · Currency is EUR
6.76
-0.04 (-0.59%)
Aug 1, 2025, 5:29 PM CET

Hyloris Pharmaceuticals Revenue

In the year 2024, Hyloris Pharmaceuticals had annual revenue of 9.76M EUR with 159.64% growth. Hyloris Pharmaceuticals had revenue of 5.12M in the half year ending December 31, 2024, with 278.14% growth.

Revenue
9.76M
Revenue Growth
+159.64%
P/S Ratio
19.39
Revenue / Employee
199.18K
Employees
49
Market Cap
189.28M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.76M6.00M159.64%
Dec 31, 20233.76M1.37M57.48%
Dec 31, 20222.39M-709.00K-22.90%
Dec 31, 20213.10M2.92M1,669.14%
Dec 31, 2020175.00K84.00K92.31%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
argenx SE2.66B
UCB SA6.85B
Financière de Tubize13.26K
Fagron NV918.75M
Ion Beam Applications498.16M
Nyxoah4.36M
Onward Medical1.74M
Sequana Medical NV105.50K
Revenue Rankings